Serum albumin level is a notable profiling factor for non‐<scp>B</scp>, non‐<scp>C</scp> hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis
Shingo Yamada(Jichi Medical University), Michio Sata(Kurume University), Manabu Satani(Kurume University), Kiminori Fujimoto, Hiroji Shima(St Mary's Hospital), Tatsuyuki Tonan(Kurume University), Michael Charlton(Madrigal Pharmaceuticals (United States)), Masahito Nakano(Kurume University), Ryoko Kuromatsu(Kurume University), Tatsuyuki Kakuma(Kurume University), Takumi Kawaguchi(Kurume University), Nobuyoshi Fukushima(Nagasaki Medical Center), Atsushi Kawaguchi(Kyoto University), Shuji Sumie(Kurume University), Akio Takata(Kurume University), Takuji Torimura(Omuta hospital)
Cited by 35
Related Papers
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536